Lawson Macartney

This profile gathers the share dealings of Lawson Macartney in Viking Therapeutics, Inc. Over a trading history stretching from 29 May 2018 to 2 January 2026, the count stands at 10 filings.

Both buying and selling appear: 1 purchase worth €217k, against 4 sales worth €1.2M. Netting one side against the other leaves €962k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant and 4 option exercises.

The newest entry dates from 5 January 2026: a share grant, in Viking Therapeutics, Inc. The latest purchase dates back some time: it was published 3,084 days ago, on 31 May 2018. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.